DOJ Settles $541.5 Million with TVH Over Medicare Advantage Violations

In an unprecedented agreement, the United States Department of Justice (DOJ) has reached a USD 541.5 million settlement with The Villages Health System LLC (TVH), spotlighting significant outcomes for violations related to Medicare Advantage risk-adjustment claims.

The matter has garnered attention due to allegations that TVH, from 2020 to 2024, submitted unauthorized diagnosis codes, leading to inflated Medicare Advantage payments. This marks one of the largest settlements of its kind, underscoring the DOJ's heightened scrutiny of MA coding practices. TVH's strategic revenue cycle management initiatives, known as "Retrospective Amendments" and "Sprints," facilitated the adjustment of diagnostic codes, allegedly without proper clinical input or initial input from healthcare providers.

Strategic Initiatives Under Scrutiny

TVH's actions came under the spotlight following its implementation of two revenue-enhancing initiatives. These initiatives allowed non-clinical staff to modify diagnostic codes post-consultation, aiming to secure higher reimbursements. Notably, approvals were often granted by providers who didn’t see the patients firsthand, highlighting a structural deficiency that the DOJ flagged as problematic. While retrospective reviews can be valid, the DOJ's intervention was triggered by the large-scale, systematic pattern, driven more by revenue goals than clinical accuracy. The risk-adjusted payments were calibrated to reflect more severe conditions than initially diagnosed, prompting questions about compliance with federal healthcare regulations.

Legal and Financial Implications

TVH's journey to resolution involved several corrective measures, including internal audits and external advisories. Eventually, TVH filed findings through the Health Care Fraud Self-Disclosure Protocol in late 2024, contributing to the DOJ’s decision to move forward with the case. While TVH ultimately declared Chapter 11 bankruptcy in July 2025, the financial repercussions emphasize the high stakes involved in regulatory compliance failures.

Insight: Compliance and Risk Management

The settlement serves as a stark reminder to insurance professionals about the critical importance of compliance in MA claims management. Voluntary disclosure and cooperation, as seen in TVH's case, can lead to certain leniencies but do not absolve accountability. Key lessons for industry stakeholders include:
  • Robust compliance frameworks are critical in managing MA claims.
  • Transparent internal auditing and early self-reporting can mitigate further penalties.
  • Non-clinical interventions must align with clinical accuracy and initial assessments.

Regulatory Evolution and Industry Impact

The DOJ's continued focus on Medicare Advantage reflects a broader movement towards stringent enforcement, dovetailing with the 2026 formation of the Task Force to Eliminate Fraud and the National Fraud Enforcement Division. This case's resolution, occurring against a backdrop of USD 6.8 billion in FCA recoveries in the 2025 fiscal year, predominantly driven by healthcare, accentuates the financial impact of fraud deterrence efforts industry-wide. For insurance professionals, understanding the intricacies of regulatory compliance and incentivization structures in MAO operations remains paramount. This case underlines the necessity for insurers and healthcare providers to advance procedures ensuring accurate, justified coding practices while effectively managing associated risks.